Agenus Inc. ( AGEN) - Stock Earnings
AGEN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -10.6 million USD | 34.2 million USD |
| 2026Q1 | 39.2 million USD | 33.7 million USD |
| 2026Q2 | -550000 USD | 34.5 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
AGEN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -245.8 million USD | 156.3 million USD |
| 2024 | -227.2 million USD | 103.5 million USD |
| 2025 | 115000 USD | 114.2 million USD |
| 2026 Est. | — | — |
AGEN
Price: $7.67
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.99 USD
P/E Ratio: 2.45
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 207310
Ebitda: -30.2 millionMarket Capitalization: 348.1 million